Fostering Effective Sponsor–CDMO Collaboration (Trust vs. Oversight)

This segment of the Outsourced Pharma Live event, “Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right,” addresses how to balance trusting a CDMO as a subject-matter expert with maintaining sufficient oversight through clear KPIs, targeted on-site presence at critical milestones, and a partnership mindset where both sides work to enable each other’s success and demonstrate ongoing trustworthiness. Featuring panelists Thierry Bilbault, Co-founder and Principal at JT Biopharma Partners, and April Loui, SVP Quality and CMC Regulatory at ReCode Therapeutics, as well as Founder, CEO at Clarity Global Pharma.